A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults | Scientific Reports
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults | Scientific Reports,A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults | Scientific Reports,StopCOVID19 Japan 新型コロナウイルス対策ダッシュボードの更新終了と、NIID感染症オープンデータの収集開始のお知らせ,Clinical Characteristics of Patients with SARS-CoV-2 N501Y Variants in General Practitioner Clinic in Japan,Smart Airの購入サポート金利0%のご案内